Coronavirus Update: Ex-BARDA Chief: I Was Removed For Resisting Trump’s ‘Game Changer’ Drug
Furor Comes As Novartis Prepares Trial To Answer Data Doubts
Executive Summary
Former BARDA leader says science not politics has to lead COVID-19 decision making. Plus Bayer launches Canada partnership, Korea pools research efforts.
You may also be interested in...
US FDA Safety Alert For Hydroxychloroquine Is Latest Turn In Drug's Strange Journey
As potentially life-threatening heart problems emerge in coronavirus patients, FDA says hydroxychloroquine should be taken only in clinical trial or hospital settings under the Emergency Use Authorization.
Deal Watch: Novartis Partners With TScan To Develop T-Cell Receptor-Targeted Therapies
Novartis/TScan and Gilead/Kite/oNKo-innate partnerships seek to advance cancer cell therapy. J&J, Bayer among the latest pharmas to unveil partnerships to fight the novel coronavirus.
Coronavirus Update: Moderna Lifted By BARDA funding, Europe Looks For Exit Strategy, Vaccine Funds
Plus: Moleculin hopes to move 2-DG prodrug into clinic, India progresses niche COVID-19 defenses and more.